Original Source(s)
Related Content
FDA Clears Olastrocel Trial Expansion
Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.
June 22, 2026
-
3 min
Cross-Linked HA Did Not Outperform Saline
Two single-injection cross-linked hyaluronic acid formulations showed no statistically significant advantage over saline for pain or functional outcomes through 24 weeks.
July 10, 2026
-
4 min